240 related articles for article (PubMed ID: 28445472)
21. A novel nonsense mutation of the EXT1 gene in an Argentinian patient with multiple hereditary exostoses: a case report.
Delgado MA; Sarrión P; Azar N; Zecchini L; Robledo HH; Segura F; Balcells S; Grinberg D; Dodelson de Kremer R; Asteggiano CG
J Bone Joint Surg Am; 2012 Jun; 94(11):e76. PubMed ID: 22637216
[No Abstract] [Full Text] [Related]
22. Mice deficient in Ext2 lack heparan sulfate and develop exostoses.
Stickens D; Zak BM; Rougier N; Esko JD; Werb Z
Development; 2005 Nov; 132(22):5055-68. PubMed ID: 16236767
[TBL] [Abstract][Full Text] [Related]
23. Haploinsufficiency of EXT1 and Heparan Sulphate Deficiency Associated with Hereditary Multiple Exostoses in a Pakistani Family.
Ajmal M; Muhammad H; Nasir M; Shoaib M; Malik SA; Ullah I
Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676722
[No Abstract] [Full Text] [Related]
24. Venous malformation may be a feature of EXT1-related hereditary multiple exostoses: A report of two unrelated probands.
Albokhari D; Bailey CR; Hwang F; Weiss CR; Forsberg J; Sobreira N
Am J Med Genet A; 2023 Jun; 191(6):1570-1575. PubMed ID: 36869625
[TBL] [Abstract][Full Text] [Related]
25. Clonal karyotypic abnormalities of the hereditary multiple exostoses chromosomal loci 8q24.1 (EXT1) and 11p11-12 (EXT2) in patients with sporadic and hereditary osteochondromas.
Bridge JA; Nelson M; Orndal C; Bhatia P; Neff JR
Cancer; 1998 May; 82(9):1657-63. PubMed ID: 9576285
[TBL] [Abstract][Full Text] [Related]
26. Cell biology of osteochondromas: bone morphogenic protein signalling and heparan sulphates.
Cuellar A; Reddi AH
Int Orthop; 2013 Aug; 37(8):1591-6. PubMed ID: 23771188
[TBL] [Abstract][Full Text] [Related]
27. Assessing the general population frequency of rare coding variants in the EXT1 and EXT2 genes previously implicated in hereditary multiple exostoses.
Cousminer DL; Arkader A; Voight BF; Pacifici M; Grant SFA
Bone; 2016 Nov; 92():196-200. PubMed ID: 27616605
[TBL] [Abstract][Full Text] [Related]
28. Osteochondromas: review of the clinical, radiological and pathological features.
Kitsoulis P; Galani V; Stefanaki K; Paraskevas G; Karatzias G; Agnantis NJ; Bai M
In Vivo; 2008; 22(5):633-46. PubMed ID: 18853760
[TBL] [Abstract][Full Text] [Related]
29. EXTra hit for mouse osteochondroma.
Bovée JV
Proc Natl Acad Sci U S A; 2010 Feb; 107(5):1813-4. PubMed ID: 20133829
[No Abstract] [Full Text] [Related]
30. Etiological point mutations in the hereditary multiple exostoses gene EXT1: a functional analysis of heparan sulfate polymerase activity.
Cheung PK; McCormick C; Crawford BE; Esko JD; Tufaro F; Duncan G
Am J Hum Genet; 2001 Jul; 69(1):55-66. PubMed ID: 11391482
[TBL] [Abstract][Full Text] [Related]
31. EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas.
Bovée JV; Cleton-Jansen AM; Wuyts W; Caethoven G; Taminiau AH; Bakker E; Van Hul W; Cornelisse CJ; Hogendoorn PC
Am J Hum Genet; 1999 Sep; 65(3):689-98. PubMed ID: 10441575
[TBL] [Abstract][Full Text] [Related]
32. The neoplastic pathogenesis of solitary and multiple osteochondromas.
Porter DE; Simpson AH
J Pathol; 1999 Jun; 188(2):119-25. PubMed ID: 10398153
[TBL] [Abstract][Full Text] [Related]
33. Novel mutation in the EXT-1 gene in an Iranian family affected with hereditary multiple exostoses.
Foroughmand AM; Galehdari H; Rasouli M; Mohammadian G; Mohammadi M
Pak J Biol Sci; 2008 Apr; 11(7):1037-41. PubMed ID: 18810975
[TBL] [Abstract][Full Text] [Related]
34. Mutation spectrum of EXT1 and EXT2 in the Saudi patients with hereditary multiple exostoses.
Al-Zayed Z; Al-Rijjal RA; Al-Ghofaili L; BinEssa HA; Pant R; Alrabiah A; Al-Hussainan T; Zou M; Meyer BF; Shi Y
Orphanet J Rare Dis; 2021 Feb; 16(1):100. PubMed ID: 33632255
[TBL] [Abstract][Full Text] [Related]
35. A mouse model of osteochondromagenesis from clonal inactivation of Ext1 in chondrocytes.
Jones KB; Piombo V; Searby C; Kurriger G; Yang B; Grabellus F; Roughley PJ; Morcuende JA; Buckwalter JA; Capecchi MR; Vortkamp A; Sheffield VC
Proc Natl Acad Sci U S A; 2010 Feb; 107(5):2054-9. PubMed ID: 20080592
[TBL] [Abstract][Full Text] [Related]
36. Hereditary multiple exostoses and heparan sulfate polymerization.
Zak BM; Crawford BE; Esko JD
Biochim Biophys Acta; 2002 Dec; 1573(3):346-55. PubMed ID: 12417417
[TBL] [Abstract][Full Text] [Related]
37. Toward an understanding of the short bone phenotype associated with multiple osteochondromas.
Jones KB; Datar M; Ravichandran S; Jin H; Jurrus E; Whitaker R; Capecchi MR
J Orthop Res; 2013 Apr; 31(4):651-7. PubMed ID: 23192691
[TBL] [Abstract][Full Text] [Related]
38. Heparan sulfate abnormalities in exostosis growth plates.
Hecht JT; Hall CR; Snuggs M; Hayes E; Haynes R; Cole WG
Bone; 2002 Jul; 31(1):199-204. PubMed ID: 12110435
[TBL] [Abstract][Full Text] [Related]
39. The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate.
McCormick C; Leduc Y; Martindale D; Mattison K; Esford LE; Dyer AP; Tufaro F
Nat Genet; 1998 Jun; 19(2):158-61. PubMed ID: 9620772
[TBL] [Abstract][Full Text] [Related]
40. Clinical and radiographic analysis of osteochondromas and growth disturbance in hereditary multiple exostoses.
Porter DE; Emerton ME; Villanueva-Lopez F; Simpson AH
J Pediatr Orthop; 2000; 20(2):246-50. PubMed ID: 10739291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
